|
related topics |
{product, market, service} |
{product, candidate, development} |
{system, service, information} |
{cost, operation, labor} |
{control, financial, internal} |
{property, intellectual, protect} |
{regulation, government, change} |
{stock, price, operating} |
{customer, product, revenue} |
{acquisition, growth, future} |
|
We have a limited operating history and we have not until recently had profitable operations.
If we do not continue to enhance our software, we may not be able to meet the evolving needs of our customers.
Our quarterly results fluctuate significantly.
Our business strategies are unproven and we are in an early stage of development.
We may lose revenue if we experience delays in clinical trials or if we lose contracts.
We may lose future revenue if our major customers decrease their research and development expenditures, or if we lose any of our major customers.
Changes in government regulations relating to the health care industry could have a material adverse effect on the demand for our services.
We may not be able to capture or establish the market presence necessary to compete in the EDC market.
We may be subject to liability for potential breaches of contracts or losses relating to the unauthorized release of clinical trial data.
Our competitive position and business may be adversely affected if we are unable to protect our intellectual property rights or infringe upon the intellectual property rights of others.
We may not be able to successfully integrate our recently acquired business into our current business operations.
We will incur increased costs associated with the integration of our new product suite.
Full 10-K form ▸
|
|
related documents |
886530--3/17/2008--DATATRAK_INTERNATIONAL_INC |
886530--3/16/2009--DATATRAK_INTERNATIONAL_INC |
886530--3/16/2007--DATATRAK_INTERNATIONAL_INC |
28626--9/13/2007--LIFECORE_BIOMEDICAL_INC |
724004--6/29/2009--MESA_LABORATORIES_INC_/CO |
724004--6/30/2008--MESA_LABORATORIES_INC_/CO |
1040570--3/31/2006--ORBIMAGE_INC |
724004--6/29/2010--MESA_LABORATORIES_INC_/CO |
752294--3/26/2010--ELECTRONIC_SYSTEMS_TECHNOLOGY_INC |
64978--3/13/2006--MERCK_&_CO_INC |
23259--3/31/2006--CT_COMMUNICATIONS_INC_/NC |
874734--3/12/2008--OSTEOTECH_INC |
855683--3/17/2009--MILESTONE_SCIENTIFIC_INC/NJ |
18568--2/27/2007--COMPASS_BANCSHARES_INC |
1026650--3/7/2008--ERESEARCHTECHNOLOGY_INC_/DE/ |
1114200--2/28/2007--AMERICAN_MEDICAL_SYSTEMS_HOLDINGS_INC |
1054579--4/21/2008--HASTINGS_ENTERTAINMENT_INC |
876167--2/10/2006--PROGRESS_SOFTWARE_CORP_/MA |
1026650--3/9/2007--ERESEARCHTECHNOLOGY_INC_/DE/ |
911149--4/2/2007--MICRO_COMPONENT_TECHNOLOGY_INC |
758004--12/21/2007--NOVELL_INC |
28626--9/13/2006--LIFECORE_BIOMEDICAL_INC |
1054579--4/20/2007--HASTINGS_ENTERTAINMENT_INC |
732712--3/1/2007--VERIZON_COMMUNICATIONS_INC |
1114200--3/1/2010--AMERICAN_MEDICAL_SYSTEMS_HOLDINGS_INC |
85961--2/17/2006--RYDER_SYSTEM_INC |
1021270--3/17/2006--FAMOUS_DAVES_OF_AMERICA_INC |
893965--1/17/2006--PLATO_LEARNING_INC |
758004--5/25/2007--NOVELL_INC |
8855--9/4/2007--AMERICAN_LOCKER_GROUP_INC |
|